VHCP Management III, LLC, 10% Owner at KalVista Pharmaceuticals, Inc. (KALV), bought 140,046 shares at $8.89 ($1.2M) on 2025-01-31, disclosed to the SEC on 2025-02-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.76 | 43,707 | $383K | 30.8% |
| 2 | $8.76 | 43,707 | $383K | 30.8% |
| 3 | $8.89 | 11,754 | $104K | 8.4% |
| 4 | $8.89 | 11,754 | $104K | 8.4% |
| 5 | $9.22 | 14,562 | $134K | 10.8% |
| 6 | $9.22 | 14,562 |
| $134K |
| 10.8% |
| Total | $8.88 avg | 140,046 | $1.2M | 100% |
| Filing → |
| BLPH | BUY | 2018-09-17 | $252K | — | Filing → |